Want to join the conversation?
Chipmaker $MU's profit dropped in 1Q17, hurt by higher restructuring and asset impairment charges. Net income was $180MM or $0.16 per diluted share compared to $206MM or $0.19 per diluted share a year ago. Revenue increased 19% to $3.97Bil, helped by increases in DRAM and trade NAND sales volumes. Non-GAAP EPS was $0.32 versus $0.29 in 1Q16.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?